• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A missed opportunity for timely intervention to prevent a life-threatening event.

作者信息

Khan Mohsin, Nangia Vikram, Bhatia Atul, Mortada M Eyman, Niazi Imran, Jahangir Arshad

机构信息

Aurora Cardiovascular and Thoracic Services, Advocate Aurora Health, Milwaukee, Wisconsin.

Center for Advanced Atrial Fibrillation Therapies, Advocate Aurora Health, Milwaukee, Wisconsin.

出版信息

HeartRhythm Case Rep. 2022 Jan 27;8(4):280-283. doi: 10.1016/j.hrcr.2022.01.011. eCollection 2022 Apr.

DOI:10.1016/j.hrcr.2022.01.011
PMID:35497472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9039103/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef87/9039103/5d3e72ed34b6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef87/9039103/511eb6019e49/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef87/9039103/596fc63c417c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef87/9039103/5d3e72ed34b6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef87/9039103/511eb6019e49/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef87/9039103/596fc63c417c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef87/9039103/5d3e72ed34b6/gr3.jpg

相似文献

1
A missed opportunity for timely intervention to prevent a life-threatening event.一次错失的及时干预机会，以防止危及生命的事件发生。
HeartRhythm Case Rep. 2022 Jan 27;8(4):280-283. doi: 10.1016/j.hrcr.2022.01.011. eCollection 2022 Apr.
2
Outcomes after asystole events occurring during wearable defibrillator-cardioverter use.可穿戴式除颤器-复律器使用期间发生心搏停止事件后的结果。
World J Cardiol. 2018 Apr 26;10(4):21-25. doi: 10.4330/wjc.v10.i4.21.
3
The Mysterious Case of an Athletic Woman with Recurrent Syncope and a "Normal" Heart.一名运动女性反复晕厥且心脏“正常”的神秘病例。
J Innov Card Rhythm Manag. 2019 Jul 15;10(7):3744-3749. doi: 10.19102/icrm.2019.100701. eCollection 2019 Jul.
4
Epileptic seizures associated with syncope: Ictal bradycardia and ictal asystole.与晕厥相关的癫痫发作：发作期心动过缓和发作期心搏停止。
Epilepsy Behav. 2019 Jan;90:168-171. doi: 10.1016/j.yebeh.2018.10.027. Epub 2018 Dec 19.
5
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.植入式心脏复律除颤器治疗的风险分层：可穿戴式心脏除颤器的作用。
Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31.
6
Ictal asystole in temporal lobe epilepsy before and after pacemaker implantation.起搏器植入前后颞叶癫痫发作期心搏停止
Epileptic Disord. 2008 Mar;10(1):39-44. doi: 10.1684/epd.2008.0166.
7
Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD Registry.基于护士培训项目的可穿戴式心脏复律除颤器患者的适应症及转归：奥地利可穿戴式心脏复律除颤器注册研究结果
Eur J Cardiovasc Nurs. 2019 Jan;18(1):75-83. doi: 10.1177/1474515118790365. Epub 2018 Aug 1.
8
Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.老年患者穿戴式除颤器的应用经验：来自穿戴式除颤器患者前瞻性注册研究的结果。
Heart Rhythm. 2018 Sep;15(9):1379-1386. doi: 10.1016/j.hrthm.2018.04.014. Epub 2018 Apr 18.
9
The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.美国小儿患者应用可穿戴式心脏除颤器的经验。
Circ Arrhythm Electrophysiol. 2018 Jul;11(7):e006163. doi: 10.1161/CIRCEP.117.006163.
10
Recommendations for driving after implantable cardioverter defibrillator implantation and the use of a wearable cardioverter defibrillator : Different viewpoints around the world.植入式心脏除颤器植入后驾驶建议和可穿戴式心脏除颤器的使用：世界各地的不同观点。
Wien Klin Wochenschr. 2020 Dec;132(23-24):770-781. doi: 10.1007/s00508-020-01675-0. Epub 2020 May 20.

本文引用的文献

1
Wearable Cardioverter-Defibrillator after Myocardial Infarction.心肌梗死后的可穿戴式心脏除颤器。
N Engl J Med. 2018 Sep 27;379(13):1205-1215. doi: 10.1056/NEJMoa1800781.
2
Outcomes after asystole events occurring during wearable defibrillator-cardioverter use.可穿戴式除颤器-复律器使用期间发生心搏停止事件后的结果。
World J Cardiol. 2018 Apr 26;10(4):21-25. doi: 10.4330/wjc.v10.i4.21.
3
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
2017年美国心脏协会/美国心脏病学会/心律学会室性心律失常患者管理和心脏性猝死预防指南：美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会的报告
Heart Rhythm. 2018 Oct;15(10):e73-e189. doi: 10.1016/j.hrthm.2017.10.036. Epub 2017 Oct 30.
4
The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.真实临床环境中的可穿戴式心脏复律除颤器：102例连续患者的经验
Clin Res Cardiol. 2017 Apr;106(4):300-306. doi: 10.1007/s00392-016-1054-1. Epub 2016 Nov 25.
5
Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).可穿戴式心脏除颤器在高危心脏患者中的应用：来自前瞻性可穿戴式心脏除颤器（WEARIT-II 注册研究）患者使用登记数据库的数据。
Circulation. 2015 Oct 27;132(17):1613-9. doi: 10.1161/CIRCULATIONAHA.115.015677. Epub 2015 Aug 27.
6
Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.穿戴式心脏除颤器在心肌梗死后早期被认为高危患者中的应用。
J Am Coll Cardiol. 2013 Nov 19;62(21):2000-2007. doi: 10.1016/j.jacc.2013.05.086. Epub 2013 Jul 31.
7
Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.可穿戴式除颤器的综合国家经验：事件发生率、依从性和生存率。
J Am Coll Cardiol. 2010 Jul 13;56(3):194-203. doi: 10.1016/j.jacc.2010.04.016.